Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-cell synovial profiling to optimize upadacitinib therapy in RA and PsA
jRCTs031230485Recruiting
- Sponsor
- AbbVie Inc.
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of upadacitinib in rheumatoid arthritis (RA) and psoriatic arthritis (PsA), sponsored by AbbVie Inc. Started Dec 2023; status: recruiting.
02
Drugs
upadacitinib
03
Conditions
rheumatoid arthritis (RA)psoriatic arthritis (PsA)
Beyond the preview
Go deeper on jRCTs031230485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230485.